<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04318691</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A00217-32</org_study_id>
    <nct_id>NCT04318691</nct_id>
  </id_info>
  <brief_title>Netosis in Determination of Respiratory Infection Severity</brief_title>
  <acronym>NETMINDERS</acronym>
  <official_title>Netosis in Mechanically Ventilated ICU Patients in Determination of Respiratory Infection Severity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to evaluate the prognostic value of alveolar and blood NETosis in patients&#xD;
      under mechanical ventilation and treated for an acute low-respiratory tract infection. The&#xD;
      main outcome is the occurrence of an acute respiratory distress syndrome (ARDS) according to&#xD;
      the Berlin definition.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neutrophils are the first line of defense against infectious injury. Among the numerous&#xD;
      mechanisms involving the immune system, neutrophil extracellular traps (NETs) have been&#xD;
      recently described as an additional way neutrophils are able to use to fight against&#xD;
      bacteria. NETs are made of DNA and antimicrobial proteins. In the other hand, NETs promote&#xD;
      coagulation and may contribute to evolution of severe pneumonia into acute respiratory&#xD;
      distress syndrome.&#xD;
&#xD;
      The secondary objectives of the study include the research of the relation between blood&#xD;
      NETosis and alveolar NETosis with:&#xD;
&#xD;
        -  the documentation of invasive pulmonary infection based on microbiological analysis&#xD;
           criteria (which would be bacteria or viral) of LBA at admission to ICU;&#xD;
&#xD;
        -  the diagnosis value of usually used biomarkers: procalcitonin and C-reactive protein;&#xD;
&#xD;
        -  marbrure score at admission to ICU;&#xD;
&#xD;
        -  arterial lactatemia;&#xD;
&#xD;
        -  scores of gravity at admission IGSII and SOFA;&#xD;
&#xD;
        -  all-cause mortality at day-28;&#xD;
&#xD;
        -  duration of mechanical ventilation at day-28;&#xD;
&#xD;
        -  duration of amines at day-28;&#xD;
&#xD;
        -  developement of hemodynamic failure;&#xD;
&#xD;
        -  developement of pulmonary circulatory failure.&#xD;
&#xD;
      The study will include 1) 60 patients under mechanical ventilation admitted to the intensive&#xD;
      care unit for acute respiratory failure, 2) 10 control patients admitted to the ICU after a&#xD;
      planned vascular surgery and 3) 10 healthy subjects.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Acute respiratory distress syndrome occurrence</measure>
    <time_frame>at day-7</time_frame>
    <description>Acute respiratory distress syndrome occurrence according to the Berlin definition within the first 7 days after ICU admission</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>At day-28</time_frame>
    <description>Vital statue of patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>At day-28</time_frame>
    <description>Duration of mechanical ventilation: number of days without mechanical ventilation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IGSII score</measure>
    <time_frame>At admission to ICU</time_frame>
    <description>IGSII score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA score</measure>
    <time_frame>At admission to ICU</time_frame>
    <description>SOFA score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic failure</measure>
    <time_frame>At day-28</time_frame>
    <description>Development of a hemodynamic failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary circulation failure</measure>
    <time_frame>At day-28</time_frame>
    <description>Development of a pulmonary circulation failure (acute pulmonary heart disease, right ventricle failure)</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Respiratory Infection</condition>
  <arm_group>
    <arm_group_label>acute respiratory failure group</arm_group_label>
    <description>60 patients under mechanical ventilation admitted to the intensive care unit for acute respiratory failure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vascular surgery control group</arm_group_label>
    <description>10 control patients admitted to the ICU after a planned vascular surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy volunteers group</arm_group_label>
    <description>10 healthy subjects.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood sampling</intervention_name>
    <description>Blood sampling at baseline and at day-3 (10 ml, EDTA tube), test of NETs.</description>
    <arm_group_label>Healthy volunteers group</arm_group_label>
    <arm_group_label>acute respiratory failure group</arm_group_label>
    <arm_group_label>vascular surgery control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bronchoalveolar lavage</intervention_name>
    <description>Bronchoalveolar lavage at admission to the ICU with analysis of cytological, bacteriological, viral and anatomopathological, and test of NETs.</description>
    <arm_group_label>acute respiratory failure group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        -  Adult ICU patients under mechanical ventilation with suspected lower-respiratory tract&#xD;
             infection;&#xD;
&#xD;
          -  Adult ICU patients followed vascular surgical intervention;&#xD;
&#xD;
          -  Healthy Volunteers.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
        A/ For all subjets:&#xD;
&#xD;
          -  Be &gt;/= 18 years of age on day of signing informed consent;&#xD;
&#xD;
          -  Affiliated to the french social security - welfare system in France.&#xD;
&#xD;
        B/ Inclusion criteria for acute respiratory failure patients:&#xD;
&#xD;
        admitted to the ICU for acute respiratory failure requiring mechanical ventilation within&#xD;
        the first 24 hours after admission and suspected to suffer from an infectious pneumonia,&#xD;
        according to the following criteria:&#xD;
&#xD;
          -  recent fever;&#xD;
&#xD;
          -  acute respiratory failure signs (dyspnea, polypnea &gt; 30 cycles/min, hypoxemia PaO2&lt;65&#xD;
             mmHg);&#xD;
&#xD;
          -  pulmonary focal signs of auscultation;&#xD;
&#xD;
          -  evocative signs in chest radiography or chest TDM.&#xD;
&#xD;
        C/ Inclusion criteria for control patients:&#xD;
&#xD;
        - admitted to the ICU for post-operative management of vascular surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        A/ For all subjets:&#xD;
&#xD;
          -  pregnancy,&#xD;
&#xD;
          -  nosocomial pneumonia,&#xD;
&#xD;
          -  no social health insurance,&#xD;
&#xD;
          -  neutropenia of any cause;&#xD;
&#xD;
          -  patient refusal.&#xD;
&#xD;
        B/ Exclusion criteria for acute respiratory failure patients:&#xD;
&#xD;
        - no mechanical ventilation within the first 24 hours after admission to the ICU.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mathieu Godement, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de médecine intensive réanimation, Hôpital Ambroise Paré, APHP</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Guillaume Geri, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Service de médecine intensive réanimation, Hôpital Ambroise Paré, APHP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mathieu Godement, MD</last_name>
    <phone>+33 1 49095603</phone>
    <email>mathieu.godement@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guillaume Geri, MD, PhD</last_name>
    <phone>+33 1 49095601</phone>
    <email>guillaume.geri@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de médecine intensive réanimation, Hôpital Ambroise Paré, APHP</name>
      <address>
        <city>Boulogne-Billancourt</city>
        <zip>92100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 20, 2020</study_first_submitted>
  <study_first_submitted_qc>March 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2020</study_first_posted>
  <last_update_submitted>September 22, 2021</last_update_submitted>
  <last_update_submitted_qc>September 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>acute respiratory distress syndrome</keyword>
  <keyword>adult ICU</keyword>
  <keyword>neutrophil extracellular traps (NETs)</keyword>
  <keyword>Netosis</keyword>
  <keyword>neutrophils</keyword>
  <keyword>mechanical ventilation</keyword>
  <keyword>pneumonia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

